Inventor · disambiguated record
Gregory Chin
Also filed as: CHIN GREGORY · CHIN GREGORY F
18 granted patents·12 pending applications·231 citations·filing 2014–2025
93Inventor score
Files withGILEAD SCIENCES INC30
Top patents by PatentIndex Score
30 records- 0198US10640499B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 5, 2020·32 cites·10 claims
- 0298US10370342B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted Aug 6, 2019·30 cites·13 claims
- 0398US9670205B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 6, 2017·100 cites·16 claims
- 0497US11827609B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Nov 28, 2023·4 cites·11 claims
- 0596US11179397B2Imidazopyrimidine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·23 cites·13 claims
- 0696US10285990B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 14, 2019·11 cites·6 claims
- 0792US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 0892US11124487B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Granted Sep 21, 2021·8 cites·14 claims
- 0990US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 1089US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1183US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1277US12377100B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Aug 5, 2025·0 cites·5 claims
- 1376US2025002513A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1475US12264173B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 1575US11919869B2CD73 compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 5, 2024·0 cites·27 claims
- 1675US2024279186A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1775US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1874US2023295201A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1968US2025270174A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2067US2025230168A1Azaspiro wrn inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2165US2022241281A1Imidazopyrimidine DerivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2264US12110294B2CD73 compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·7 claims
- 2364US11767337B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 26, 2023·0 cites·43 claims
- 2464US2024116928A1Cd73 compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2563US12030903B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 9, 2024·0 cites·33 claims
- 2662US2019282576A1Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2761US2022356196A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2855US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2952US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 3047US2025276979A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory Chin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →